venBio Select Advisor »

Definium Therape shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2026-03-31 $95M 5.0M 18.90

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Ascendis Pharma Sponsored ADR (ASND)
Madrigal Pharmaceuticals Common (MDGL)
Krystal Biotech Common (KRYS)
Argenx Se Sponsored ADR (ARGX)
Arrowhead Pharmaceuticals Common (ARWR)
Kymera Therapeutics Common (KYMR)
Apellis Pharmaceuticals Common (APLS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Xenon Pharmaceuticals Common (XENE)
Structure Therapeutics Sponsored Ads (GPCR)
Terns Pharmaceuticals Common (TERN)
Vera Therapeutics Common (VERA)
Revolution Medicines Common (RVMD)
Cytokinetics Common (CYTK)

View all positions for venBio Select Advisor

Top funds holding Definium Therape

BlackRock
Driehaus Capital Management
venBio Select Advisor
Henderson Group
Deep Track Capital
Geode Capital Management
State Street Corporation
Octagon Capital Advisors
Commodore Capital
FMR
Trails Edge Capital Partners
Goldman Sachs Group
Arrowpoint Asset Management
Citadel Advisors
Wellington Management Company

View all funds holding Definium Therape